Lilly’s Kisunla approved by FDA for the treatment of early symptomatic Alzheimer’s disease

Press/Media

Period	5 Jul 2024

Media coverage

Title	Lilly’s Kisunla approved by FDA for the treatment of early symptomatic Alzheimer’s disease
Media name/outlet	Pharma Business International
Country/Territory	United Kingdom
Date	5/07/24
URL	ct.moreover.com/?a=54224536707&p=1gw&v=1&x=q2kCSrY1YXWPnpp3PsyT0g
Persons	Howard Fillit